|
|
|
|
|
|
Kristin joined Health Advances in 2002 with extensive experience as a research scientist in
the diagnostics and drug discovery industries. Prior to joining Health Advances, Kristin
focused on genetic test and technology development at Genzyme and in genomics research at
Genome Therapeutics (now Oscient Pharmaceuticals).
Kristin now leads the diagnostics and discovery tools practice at Health Advances, combining
her consulting and scientific experience to provide results-oriented strategy for her clients
in the biotech and clinical diagnostics sectors, including focus on launch strategy, pricing,
and R&D prioritization for novel diagnostics and biotech tools for the research laboratory,
personalized medicine, point-of-care, and mainstream clinical diagnostics. Kristin's clients
range from small diagnostics and tools start-ups to the largest public companies in the industry.
Kristin received her Bachelors degree in Biochemistry from Smith College and her Masters degree
in Epidemiology, Health Management, and Maternal and Child Health from the Harvard School of Public Health.
|
|
 |
|
|
|
|
